Package 68475-003-04

Brand: ribavirin

Generic: ribavirin
NDC Package

Package Facts

Identity

Package NDC 68475-003-04
Digits Only 6847500304
Product NDC 68475-003
Product ID 68475-003_76819c30-2ece-43cf-a329-6bc3720ac870
Description

4 VIAL in 1 CARTON (68475-003-04) / 1 POWDER, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2020-04-21
Brand ribavirin
Generic ribavirin
Sample Package No

Linked Drug Pages (1)

RIBAVIRIN ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "76819c30-2ece-43cf-a329-6bc3720ac870", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["312818"], "spl_set_id": ["39723ea2-780c-4266-954a-869723b144c4"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Navinta LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (68475-003-04)  / 1 POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "68475-003-04", "marketing_start_date": "20200421"}], "brand_name": "RIBAVIRIN", "product_id": "68475-003_76819c30-2ece-43cf-a329-6bc3720ac870", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68475-003", "generic_name": "ribavirin", "labeler_name": "Navinta LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIBAVIRIN", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "6 g/1"}], "application_number": "ANDA207366", "marketing_category": "ANDA", "marketing_start_date": "20200421", "listing_expiration_date": "20261231"}